Back to Search Start Over

Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma.

Authors :
Su J
Zhong G
Qin W
Zhou L
Ye J
Ye Y
Chen C
Liang P
Zhao W
Xiao X
Wen W
Luo W
Zhou X
Zhang Z
Cai Y
Li C
Source :
Discover oncology [Discov Oncol] 2024 Apr 11; Vol. 15 (1), pp. 112. Date of Electronic Publication: 2024 Apr 11.
Publication Year :
2024

Abstract

Background: Dysregulation of iron metabolism has been shown to have significant implications for cancer development. We aimed to investigate the prognostic and immunological significance of iron metabolism-related genes (IMRGs) in nasopharyngeal carcinoma (NPC).<br />Methods: Multiple Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) datasets were analyzed to identify key IMRGs associated with prognosis. Additionally, the immunological significance of IMRGs was explored.<br />Results: A novel risk model was established using the LASSO regression algorithm, incorporating three genes (TFRC, SLC39A14, and ATP6V0D1).This model categorized patients into low and high-risk groups, and Kaplan-Meier analysis revealed significantly shorter progression-free survival for the high-risk group (Pā€‰<ā€‰0.0001). The prognostic model's accuracy was additionally confirmed by employing time-dependent Receiver Operating Characteristic (ROC) curves and conducting Decision Curve Analysis (DCA). High-risk patients were found to correlate with advanced clinical stages, specific tumor microenvironment subtypes, and distinct morphologies. ESTIMATE analysis demonstrated a significant inverse relationship between increased immune, stromal, and ESTIMATE scores and lowered risk score. Immune analysis indicated a negative correlation between high-risk score and the abundance of most tumor-infiltrating immune cells, including dendritic cells, CD8 <superscript>+</superscript> T cells, CD4 <superscript>+</superscript> T cells, and B cells. This correlation extended to immune checkpoint genes such as PDCD1, CTLA4, TIGIT, LAG3, and BTLA. The protein expression patterns of selected genes in clinical NPC samples were validated through immunohistochemistry.<br />Conclusion: This study presents a prognostic model utilizing IMRGs in NPC, which could assist in assessing patient prognosis and provide insights into new therapeutic targets for NPC.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
2730-6011
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Discover oncology
Publication Type :
Academic Journal
Accession number :
38602575
Full Text :
https://doi.org/10.1007/s12672-024-00969-3